CXCR5 and lymphoma: In non‐POD24‐FLs, weak CCR3, CXCR3, and CXCR4 expression was observed in 50%, 11.8%, and 40% of lymphoma cells, respectively, while moderate CXCR5 and strong CCR7 expression was detected in 68.3% and 50% (Figure 5b; Table 2).